Company
United StatesPublic company, NASDAQ: LINLinde, Inc. (NASDAQ: LIN), Inver Grove Heights, MN – FDA Inspections
Inspection records and compliance data for Linde, Inc. in Inver Grove Heights, Minnesota. 1 FDA inspection on record, last inspected March 27, 2014. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde, Inc. based in Inver Grove Heights, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 27, 2014.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 27, 2014 | NAI | Human Drugs · Drug Quality Assurance | 873928 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde, Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
2127718
Address
11499 Courthouse Blvd, Inver Grove Heights, Minnesota 55077, United States
Country
United States
ID: 2f2de8fb-dbf0-41b7-be1b-55d7610d7f8c